Explanatory review report of Qingdao Weilan Biology Co., Ltd. on the acquisition of Qingdao Runbote Biotechnology Co., Ltd. and the fulfillment of its 2023 performance promise
Announcement of Qingdao Weilan Biology Co., Ltd. on the use of idle funds raised to purchase wealth management products at maturity and redemption
Announcement of Qingdao Weilan Biology Co., Ltd. on the use of idle funds raised to purchase wealth management products at maturity and redemption
Weilan Biotech: Qingdao Weilan Biotech Co., Ltd.\'s 2021 Annual Equity Distribution Implementation Notice
Qingdao Weilan Biology Co., Ltd.'s 2021 Annual Equity Distribution Implementation Notice
Announcement of Qingdao Weilan Biology Co., Ltd. on the use of idle funds raised to purchase wealth management products at maturity and redemption
Summary report of Zhongtai Securities Co., Ltd. on the initial public offering of shares and continued supervision and sponsorship of Qingdao Weilan Biotech Co., Ltd.
Weilan Biotech: Announcement of Qingdao Weilan Biotech Co., Ltd.'s 2021 profit distribution plan
Announcement of Qingdao Weilan Biology Co., Ltd. on the use of idle funds raised to purchase wealth management products at maturity and redemption
Announcement of Qingdao Weilan Biology Co., Ltd. on the use of idle funds raised to purchase wealth management products at maturity and redemption
Weilan Biotech: Announcement on the progress of asset sale and related transactions
No Data